Trading at $0.35, Avenue Therapeutics, Inc. (ATXI) is publicly traded in the U.S. valued at $1.11M. MoonshotScore rates it 52/100 — Hold. AI signals are mixed — do more research.

For informational purposes only. Not financial advice.